Xilio Therapeutics

Simon Tomlinson - CEO

Country: USA | Funding: $294.3M (+)

Website: https://xiliotx.com/

Xilio Therapeutics is a biopharmaceutical company focused on developing highly-potent, targeted immuno-oncology therapeutics.

Competitors